ARTIVION, INC. Share-based Payment Arrangement, Expensed and Capitalized, Amount
ARTIVION, INC. (AORT) reported Share-based Payment Arrangement, Expensed and Capitalized, Amount of $24.39 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Expensed and Capitalized, Amount
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 · last filed 2026-02-18
- ARTIVION, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2024-12-31 was $2.90M, a 29.63% decline year-over-year.
- ARTIVION, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2024-09-30 was $3.94M, a 16.16% increase year-over-year.
- ARTIVION, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2024-06-30 was $4.46M, a 8.18% increase year-over-year.
- ARTIVION, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2024-03-31 was $3.67M, a 4.53% increase year-over-year.
- ARTIVION, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2025 was $24.39M, a 62.91% increase from fiscal 2024.
- ARTIVION, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2024 was $14.97M, a 1.18% decline from fiscal 2023.
- ARTIVION, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2023 was $15.15M, a 17.03% increase from fiscal 2022.
- ARTIVION, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2022 was $12.94M, a 14.76% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expensed and Capitalized, Amount 3 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 6 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 9 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 12 month |
|---|---|---|---|---|
| 2025-12-31 | $24.39M 10-K · filed 2026-02-18 | |||
| 2024-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $6.84M derived: sum of 2 quarters · filed 2026-02-18 | $11.30M derived: sum of 3 quarters · filed 2026-02-18 | $14.97M 10-K · filed 2026-02-18 |
| 2024-09-30 | $3.94M 10-Q · filed 2024-11-08 | $8.40M derived: sum of 2 quarters · filed 2024-11-08 | $12.07M 10-Q · filed 2024-11-08 | $16.19M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-06-30 | $4.46M 10-Q · filed 2024-08-09 | $8.13M 10-Q · filed 2024-08-09 | $12.25M derived: sum of 3 quarters · filed 2026-02-18 | $15.64M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-03-31 | $3.67M 10-Q · filed 2024-05-07 | $7.79M derived: sum of 2 quarters · filed 2026-02-18 | $11.19M derived: sum of 3 quarters · filed 2026-02-18 | $15.30M derived: sum of 4 quarters · filed 2026-02-18 |
| 2023-12-31 | $4.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $7.51M derived: sum of 2 quarters · filed 2026-02-18 | $11.63M derived: sum of 3 quarters · filed 2026-02-18 | $15.15M 10-K · filed 2026-02-18 |
| 2023-09-30 | $3.39M 10-Q · filed 2024-11-08 | $7.51M derived: sum of 2 quarters · filed 2024-11-08 | $11.03M 10-Q · filed 2024-11-08 | $14.31M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $4.12M 10-Q · filed 2024-08-09 | $7.63M 10-Q · filed 2024-08-09 | $10.92M derived: sum of 3 quarters · filed 2025-02-28 | $14.15M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $3.51M 10-Q · filed 2024-05-07 | $6.80M derived: sum of 2 quarters · filed 2025-02-28 | $10.03M derived: sum of 3 quarters · filed 2025-02-28 | $13.12M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $6.52M derived: sum of 2 quarters · filed 2025-02-28 | $9.60M derived: sum of 3 quarters · filed 2025-02-28 | $12.94M 10-K · filed 2025-02-28 |
| 2022-09-30 | $3.23M 10-Q · filed 2023-11-03 | $6.31M derived: sum of 2 quarters · filed 2023-11-03 | $9.65M 10-Q · filed 2023-11-03 | $13.04M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $3.08M 10-Q · filed 2023-08-04 | $6.42M 10-Q · filed 2023-08-04 | $9.80M derived: sum of 3 quarters · filed 2024-02-23 | $12.79M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $3.34M 10-Q · filed 2023-05-05 | $6.72M derived: sum of 2 quarters · filed 2024-02-23 | $9.71M derived: sum of 3 quarters · filed 2024-02-23 | $11.98M derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $6.37M derived: sum of 2 quarters · filed 2024-02-23 | $8.64M derived: sum of 3 quarters · filed 2024-02-23 | $11.28M 10-K · filed 2024-02-23 |
| 2021-09-30 | $2.99M 10-Q · filed 2022-11-04 | $5.26M derived: sum of 2 quarters · filed 2022-11-04 | $7.89M 10-Q · filed 2022-11-04 | $7.51M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $2.27M 10-Q · filed 2022-08-05 | $4.90M 10-Q · filed 2022-08-05 | $4.52M derived: sum of 3 quarters · filed 2023-02-23 | $7.04M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $2.64M 10-Q · filed 2022-05-06 | $2.25M derived: sum of 2 quarters · filed 2023-02-23 | $4.77M derived: sum of 3 quarters · filed 2023-02-23 | $7.45M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$384.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.13M derived: sum of 2 quarters · filed 2023-02-23 | $4.82M derived: sum of 3 quarters · filed 2023-02-23 | $7.50M 10-K · filed 2023-02-23 |
| 2020-09-30 | $2.52M 10-Q · filed 2021-11-05 | $5.20M derived: sum of 2 quarters · filed 2021-11-05 | $7.89M 10-Q · filed 2021-11-05 | $10.26M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $2.68M 10-Q · filed 2021-07-30 | $5.37M 10-Q · filed 2021-07-30 | $7.74M derived: sum of 3 quarters · filed 2022-02-22 | $10.36M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $2.69M 10-Q · filed 2021-04-30 | $5.06M derived: sum of 2 quarters · filed 2022-02-22 | $7.68M derived: sum of 3 quarters · filed 2022-02-22 | $10.12M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $4.99M derived: sum of 2 quarters · filed 2022-02-22 | $7.43M derived: sum of 3 quarters · filed 2022-02-22 | $9.41M 10-K · filed 2022-02-22 |
| 2019-09-30 | $2.62M 10-Q · filed 2020-11-05 | $5.06M derived: sum of 2 quarters · filed 2020-11-05 | $7.04M 10-Q · filed 2020-11-05 | $8.80M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $2.44M 10-Q · filed 2020-07-31 | $4.42M 10-Q · filed 2020-07-31 | $6.18M derived: sum of 3 quarters · filed 2021-02-23 | $7.87M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $1.98M 10-Q · filed 2020-05-01 | $3.74M derived: sum of 2 quarters · filed 2021-02-23 | $5.43M derived: sum of 3 quarters · filed 2021-02-23 | $7.43M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $3.45M derived: sum of 2 quarters · filed 2021-02-23 | $5.45M derived: sum of 3 quarters · filed 2021-02-23 | $6.81M 10-K · filed 2021-02-23 |
| 2018-09-30 | $1.69M 10-Q · filed 2019-10-31 | $3.70M derived: sum of 2 quarters · filed 2019-10-31 | $5.05M 10-Q · filed 2019-10-31 | $6.42M derived: sum of 4 quarters · filed 2019-10-31 |
| 2018-06-30 | $2.00M 10-Q · filed 2019-07-31 | $3.36M 10-Q · filed 2019-07-31 | $4.73M derived: sum of 3 quarters · filed 2019-07-31 | $6.70M derived: sum of 4 quarters · filed 2019-07-31 |
| 2018-03-31 | $1.35M 10-Q · filed 2019-05-02 | $2.73M derived: sum of 2 quarters · filed 2019-05-02 | $4.69M derived: sum of 3 quarters · filed 2019-05-02 | $6.80M derived: sum of 4 quarters · filed 2019-05-02 |
| 2017-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.34M derived: sum of 2 quarters · filed 2019-02-26 | $5.45M derived: sum of 3 quarters · filed 2019-02-26 | $7.31M 10-K · filed 2019-02-26 |
| 2017-09-30 | $1.97M 10-Q · filed 2018-11-01 | $4.08M derived: sum of 2 quarters · filed 2018-11-01 | $5.94M 10-Q · filed 2018-11-01 | $7.72M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $2.11M 10-Q · filed 2018-08-07 | $3.97M 10-Q · filed 2018-08-07 | $5.76M derived: sum of 3 quarters · filed 2019-02-26 | $7.58M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $1.86M 10-Q · filed 2018-05-04 | $3.65M derived: sum of 2 quarters · filed 2019-02-26 | $5.46M derived: sum of 3 quarters · filed 2019-02-26 | $7.00M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.60M derived: sum of 2 quarters · filed 2019-02-26 | $5.13M derived: sum of 3 quarters · filed 2019-02-26 | $6.60M 10-K · filed 2019-02-26 |
| 2016-09-30 | $1.82M 10-Q · filed 2017-10-31 | $3.35M derived: sum of 2 quarters · filed 2017-10-31 | $4.82M 10-Q · filed 2017-10-31 | $6.23M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | $1.53M 10-Q · filed 2017-07-25 | $3.00M 10-Q · filed 2017-07-25 | $4.41M derived: sum of 3 quarters · filed 2018-03-09 | $5.04M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | $1.47M 10-Q · filed 2017-04-27 | $2.88M derived: sum of 2 quarters · filed 2018-03-09 | $3.51M derived: sum of 3 quarters · filed 2018-03-09 | $5.62M derived: sum of 4 quarters · filed 2018-03-09 |
| 2015-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $2.04M derived: sum of 2 quarters · filed 2018-03-09 | $4.15M derived: sum of 3 quarters · filed 2018-03-09 | $5.33M 10-K · filed 2018-03-09 |
| 2015-09-30 | $632.00K 10-Q · filed 2016-10-27 | $2.74M derived: sum of 2 quarters · filed 2016-10-27 | $3.92M 10-Q · filed 2016-10-27 | $4.67M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-06-30 | $2.11M 10-Q · filed 2016-07-26 | $3.29M 10-Q · filed 2016-07-26 | $4.04M derived: sum of 3 quarters · filed 2017-02-16 | $5.20M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-03-31 | $1.17M 10-Q · filed 2016-04-29 | $1.92M derived: sum of 2 quarters · filed 2017-02-16 | $3.09M derived: sum of 3 quarters · filed 2017-02-16 | $3.95M derived: sum of 4 quarters · filed 2017-02-16 |
| 2014-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $1.91M derived: sum of 2 quarters · filed 2017-02-16 | $2.78M derived: sum of 3 quarters · filed 2017-02-16 | $3.70M 10-K · filed 2017-02-16 |
| 2014-09-30 | $1.16M 10-Q · filed 2015-10-27 | $2.03M derived: sum of 2 quarters · filed 2015-10-27 | $2.95M 10-Q · filed 2015-10-27 | $3.89M derived: sum of 4 quarters · filed 2016-02-16 |
| 2014-06-30 | $865.00K 10-Q · filed 2015-07-28 | $1.78M 10-Q · filed 2015-07-28 | $2.73M derived: sum of 3 quarters · filed 2016-02-16 | $3.58M derived: sum of 4 quarters · filed 2016-02-16 |
| 2014-03-31 | $919.00K 10-Q · filed 2015-04-29 | $1.86M derived: sum of 2 quarters · filed 2016-02-16 | $2.72M derived: sum of 3 quarters · filed 2016-02-16 | |
| 2013-12-31 | $945.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | $1.80M derived: sum of 2 quarters · filed 2016-02-16 | $3.47M 10-K · filed 2016-02-16 | |
| 2013-09-30 | $853.00K 10-Q · filed 2014-10-28 | $2.52M 10-Q · filed 2014-10-28 | ||
| 2012-12-31 | $3.38M 10-K · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |